CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 211 filers reported holding CORCEPT THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $30,661 | -95.6% | 1,378 | -97.6% | 0.00% | -100.0% |
Q4 2019 | $697,000 | -48.4% | 57,597 | -39.8% | 0.01% | -50.0% |
Q3 2019 | $1,351,000 | +33.2% | 95,625 | +5.2% | 0.02% | +37.5% |
Q2 2019 | $1,014,000 | +235.8% | 90,911 | +253.5% | 0.02% | +166.7% |
Q1 2019 | $302,000 | -12.5% | 25,715 | -0.7% | 0.01% | -25.0% |
Q4 2018 | $345,000 | +5.5% | 25,896 | +10.9% | 0.01% | +33.3% |
Q3 2018 | $327,000 | +26.7% | 23,359 | +42.5% | 0.01% | 0.0% |
Q2 2018 | $258,000 | -9.5% | 16,392 | -5.5% | 0.01% | -14.3% |
Q1 2018 | $285,000 | – | 17,340 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 5,188,417 | $85,349,000 | 7.80% |
TANAKA CAPITAL MANAGEMENT INC | 144,602 | $2,379,000 | 5.69% |
INGALLS & SNYDER LLC | 6,817,540 | $112,149,000 | 5.47% |
NEXTHERA CAPITAL LP | 1,045,196 | $17,193,000 | 2.83% |
Timpani Capital Management LLC | 245,279 | $4,035,000 | 1.41% |
S&T BANK/PA | 426,257 | $7,012,000 | 1.25% |
SHAKER INVESTMENTS LLC/OH | 107,670 | $1,771,000 | 1.10% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 434,624 | $7,150,000 | 0.94% |
AMI ASSET MANAGEMENT CORP | 709,300 | $11,668,000 | 0.83% |
Birchview Capital, LP | 75,500 | $1,242,000 | 0.82% |